|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,540 KRW | +2.59% |
|
+4.72% | -2.20% |
Sinil Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 151.74 million compared to KRW 195.78 million a year ago. Net income was KRW 3,798.64 million compared to KRW 2,511.4 million a year ago.
Basic earnings per share from continuing operations was KRW 329 compared to KRW 217 a year ago. Basic earnings per share was KRW 329 compared to KRW 217 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.20% | 60.1M | |
| +20.78% | 43.29B | |
| +27.64% | 22.38B | |
| +19.25% | 15.51B | |
| +18.68% | 14.52B | |
| +54.64% | 12.93B | |
| -0.05% | 6.79B | |
| -11.39% | 6.56B | |
| +18.33% | 5.87B | |
| -8.87% | 5.73B |
SINIL PHARMACEUTICAL CO., LTD. 
